Medicines, Ethics and Practice: a guide for pharmacists

August 2003 amendments

In the first issue of each month The Journal updates the guidance on the legal status of medicines published in the 27th (July 2003) edition of 'Medicines, ethics and practice: A guide for pharmacists'.

The amendments are given in bold type when added to the list and repeated each month in light type. A product's legal status can be obtained by consulting first the latest amendment list and then the guide. The abbreviations used in the list are explained in the key to annotations in the body of the guide (p27 and p73).

Human medicines

4-Androstene-3,17-dione CD anab POM 5-Androstene-3,17-diol CD anab POM

Dihydroetorpine CD POM

Fuzeon injection POM

Gammahydroxy-butyrate [GHB] CD benz POM

4-Hydroxy-n-butyric acid CD benz POM

Metvix cream POM

Modisal preparations entry should read: Modisal XL tablets P

Monit tablets entry should read: Monit tablets P

Monit SR tablets entry should read: Monit SR tablets P

Monit XL tablets P

19-Nor-4-androstene-3,17-dione CD anab POM

19-Nor-5-androstene-3,17-diol CD anab POM

Remifentanil CD POM

Stilnoct tablets entry should read: Stilnoct tablets CD benz POM

Testogel gel CD anab POM

Ultiva injection entry should read: Ultiva injection CD POM

Zolpidem tartrate entry should read: Zolpidem tartrate CD benz POM